[ad_1] Global pharmaceutical giant Lupin Ltd. on Monday announced a significant milestone in its expansion strategy within the US market, securing tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amifampridine Tablets, 10 mg. This approval positions Lupin to tap into a substantial market opportunity […]
Explained: Why Lupin, Cipla and other Pharma stocks fell on Thursday – CNBC TV18
[ad_1] Shares of pharma companies tumbled as much as 6% on Thursday, October 10, with the Nifty Pharma index falling 2%. Pharma stocks like Lupin, Cipla, Torrent Pharma, Alkem Laboratories and Aurobindo Pharma were among major laggards. Lupin shares settled 5.58% lower at ₹2,158.50. The stock fell today after two days of consecutive gain. Cipla […]